LOX and triple-A syndrome: APN inhibited the angiotensin type-1 receptor (AT1R), inflammatory cytokine and mast cell protease expression, and induced upregulation of LOX in the aortic wall, improved systemic cytokine profile and attenuated adipose inflammation, thus preventing AAA